Demographics of participants.
BREAST CANCERS, ATTRITION
*Multiple-option item–i.e., including one participant with metastatic lung and breast cancers.The accrual rate, adjusting for the months of trial closure due to COVID-19 related issues, was 0.54 participants per month across all sites. Attrition and completion rates of participants for each study stage are shown in 